Camp4 Therapeutics Corporation
CAMP
$3.25
-$0.06-1.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.10M | -12.59M | -12.43M | -13.28M | -13.48M |
| Total Depreciation and Amortization | 416.00K | 430.00K | 421.00K | 418.00K | 418.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.84M | 1.39M | 1.45M | 1.28M | 2.06M |
| Change in Net Operating Assets | -369.00K | 428.00K | -3.72M | 297.00K | 1.31M |
| Cash from Operations | -11.22M | -10.34M | -14.29M | -11.29M | -9.69M |
| Capital Expenditure | 0.00 | 0.00 | -279.00K | -263.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 36.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 36.00K | 0.00 | -279.00K | -263.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -111.00K | 72.00K | -151.00K | -211.00K | -205.00K |
| Issuance of Common Stock | 32.57M | -- | -- | 76.43M | 31.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 14.93M | -- | -- | -3.16M | -212.00K |
| Cash from Financing | 47.38M | 72.00K | -151.00K | 73.06M | -386.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.20M | -10.27M | -14.72M | 61.51M | -10.08M |